{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:44:18Z","timestamp":1769150658942,"version":"3.49.0"},"reference-count":31,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>There are no studies comparing the prognosis for mature T-cell lymphoma (TCL) in people with HIV (PWH) to people without HIV (PWoH) and to AIDS-defining B-cell lymphomas (A-BCLs) in the modern antiretroviral therapy era. North American AIDS Cohort Collaboration on Research and Design and Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment are cohorts that enroll patients diagnosed with HIV and TCL, respectively. In our study, 52, 64, 101, 500, and 246 PWH with histologic confirmation of TCL, primary central nervous system lymphoma, Burkitt\u2019s lymphoma, diffuse large B-cell lymphoma (DLBCL), and Hodgkin\u2019s lymphoma (HL), respectively, and 450 TCLs without HIV were eligible for analysis. At the time of TCL diagnosis, anaplastic large-cell lymphoma (ALCL) was the most common TCL subtype within PWH. Although PWH with TCL diagnosed between 1996 and 2009 experienced a low 5-year survival probability at 0.23 (95% confidence interval [CI]: 0.13, 0.41), we observed a marked improvement in their survival when diagnosed between 2010 and 2016 (0.69; 95% CI: 0.48, 1; P = .04) in contrast to TCLs among PWoH (0.45; 95% CI: 0.41, 0.51; P = .53). Similarly, PWH with ALCLs diagnosed between 1996 and 2009 were associated with a conspicuously inferior 5-year survival probability (0.17; 95% CI: 0.07, 0.42) and consistently lagged behind A-BCL subtypes such as Burkitt\u2019s (0.43; 95% CI:0.33, 0.57; P\u00a0=\u00a0.09) and DLBCL (0.17; 95% CI: 0.06, 0.46; P = .11) and behind HL (0.57; 95% CI: 0.50, 0.65; P &amp;lt; .0001). Despite a small number, those diagnosed between 2010 and 2016 experienced a remarkable improvement in survival (0.67; 95% CI: 0.3, 1) in comparison with PWoH (0.76; 95% CI: 0.66, 0.87; P = .58). Thus, our analysis confirms improved overall survival for aggressive B- and T-cell malignancies among PWH in the last decade.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021006208","type":"journal-article","created":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T22:05:29Z","timestamp":1642111529000},"page":"1420-1431","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Comparative outcomes for mature T-cell and NK\/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9791-4463","authenticated-orcid":false,"given":"Min Jung","family":"Koh","sequence":"first","affiliation":[{"name":"School of Medicine, Georgetown University, Washington, DC;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4316-6938","authenticated-orcid":false,"given":"Mwanasha H.","family":"Merrill","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Ji","family":"Koh","sequence":"additional","affiliation":[{"name":"Department of Public Health, Brown University, Providence, RI;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0991-5170","authenticated-orcid":false,"given":"Robert","family":"Stuver","sequence":"additional","affiliation":[{"name":"Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3140-1128","authenticated-orcid":false,"given":"Carolyn D.","family":"Alonso","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7843-3162","authenticated-orcid":false,"given":"Francine M.","family":"Foss","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine, New-Haven, CT;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel M.","family":"Mayor","sequence":"additional","affiliation":[{"name":"Retrovirus Research Center, Universidad Central del Caribe, Bayam\u00f3n, Puerto Rico;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Gill","sequence":"additional","affiliation":[{"name":"Southern Alberta HIV Clinic, Calgary, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7605-5994","authenticated-orcid":false,"given":"Marta","family":"Epeldegui","sequence":"additional","affiliation":[{"name":"UCLA AIDS Institute, Los Angeles, CA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2452-7558","authenticated-orcid":false,"given":"Edward","family":"Cachay","sequence":"additional","affiliation":[{"name":"University of California at San Diego, San Diego, CA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[{"name":"Johns Hopkins University School of Medicine, Baltimore, MD;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9322-1395","authenticated-orcid":false,"given":"Michael J.","family":"Silverberg","sequence":"additional","affiliation":[{"name":"Division of Research Kaiser Permanente Northern California, Oakland, CA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Horberg","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Mid-Atlantic Permanente Research Institute, Rockville, MD;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5068-6595","authenticated-orcid":false,"given":"Keri N.","family":"Althoff","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ank E.","family":"Nijhawan","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, Division of Infectious Diseases, Dallas, TX;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A.","family":"McGinnis","sequence":"additional","affiliation":[{"name":"Veterans Administration Connecticut Healthcare System, West Haven, CT;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles S.","family":"Rabkin","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Rockville, MD;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Napravnik","sequence":"additional","affiliation":[{"name":"University of North Carolina, Chapel Hill, NC;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Division of HIV\/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Castilho","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Disease, Vanderbilt University Medical Center, Nashville, TN;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyu","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA;"},{"name":"Biogen, Cambridge, MA;"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1566-9308","authenticated-orcid":false,"given":"Salvia","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA;"},{"name":"Massachusetts General Hospital Cancer Center, Boston, MA; and"},{"name":"Harvard Medical School, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"issue":"25","key":"2022030921483262400_B1","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol."},{"issue":"4","key":"2022030921483262400_B2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.clml.2016.10.001","article-title":"Analysis of peripheral T-cell lymphoma diagnostic workup in the United States","volume":"17","author":"Hsi","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk."},{"issue":"5","key":"2022030921483262400_B3","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.hoc.2008.07.010","article-title":"Peripheral T-cell non-Hodgkin\u2019s lymphoma","volume":"22","author":"Vose","year":"2008","journal-title":"Hematol Oncol Clin North Am."},{"issue":"1","key":"2022030921483262400_B4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000500666","article-title":"Outcomes for relapsed and refractory peripheral T-cell lymphoma patients after front-line therapy from the COMPLETE Registry","volume":"143","author":"Lansigan","year":"2020","journal-title":"Acta Haematol."},{"issue":"9","key":"2022030921483262400_B5","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ctrv.2014.08.001","article-title":"Therapeutic options in relapsed or refractory peripheral T-cell lymphoma","volume":"40","author":"Coiffier","year":"2014","journal-title":"Cancer Treat Rev."},{"issue":"17","key":"2022030921483262400_B6","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1182\/blood-2013-12-516245","article-title":"How I treat the peripheral T-cell lymphomas","volume":"123","author":"Moskowitz","year":"2014","journal-title":"Blood."},{"issue":"7","key":"2022030921483262400_B7","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/cncr.30416","article-title":"A prospective cohort study of patients with peripheral T-cell lymphoma in the United States","volume":"123","author":"Carson","year":"2017","journal-title":"Cancer."},{"issue":"10168","key":"2022030921483262400_B8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet."},{"issue":"3","key":"2022030921483262400_B9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/ajh.21947","article-title":"Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study","volume":"86","author":"Castillo","year":"2011","journal-title":"Am J Hematol."},{"issue":"5","key":"2022030921483262400_B10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00126334-200408150-00004","article-title":"T-cell lymphoma in HIV-infected patients","volume":"36","author":"Arzoo","year":"2004","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"10","key":"2022030921483262400_B11","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/1097-0142(19931115)72:10<3078::AID-CNCR2820721033>3.0.CO;2-F","article-title":"CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus","volume":"72","author":"Chadburn","year":"1993","journal-title":"Cancer."},{"issue":"11","key":"2022030921483262400_B12","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1002\/1097-0142(19901201)66:11<2407::AID-CNCR2820661127>3.0.CO;2-N","article-title":"Angiocentric immunoproliferative lesion\/T-cell non-Hodgkin\u2019s lymphoma and the acquired immune deficiency syndrome: a case report and review of the literature","volume":"66","author":"Gold","year":"1990","journal-title":"Cancer."},{"issue":"6","key":"2022030921483262400_B13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00002030-199106000-00017","article-title":"Ki-1+ anaplastic large-cell lymphoma of T-cell origin in an HIV-infected patient","volume":"5","author":"Gonz\u00e1lez-Clemente","year":"1991","journal-title":"AIDS."},{"issue":"6","key":"2022030921483262400_B14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archderm.131.6.739","article-title":"S\u00e9zary\u2019s syndrome and human immunodeficiency virus infection","volume":"131","author":"Berger","year":"1995","journal-title":"Arch Dermatol."},{"issue":"14","key":"2022030921483262400_B15","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/QAD.0b013e32830fbd91","article-title":"HIV-associated anaplastic large cell lymphoma: a report of three cases","volume":"22","author":"Nava","year":"2008","journal-title":"AIDS."},{"issue":"1","key":"2022030921483262400_B16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000325439","article-title":"Anaplastic large cell lymphoma in a human immunodeficiency virus-positive patient with cytologic findings in bladder wash: a case report","volume":"52","author":"Proca","year":"2008","journal-title":"Acta Cytol."},{"issue":"11","key":"2022030921483262400_B17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7326\/0003-4819-111-11-871","article-title":"Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1)","volume":"111","author":"Shibata","year":"1989","journal-title":"Ann Intern Med."},{"issue":"3","key":"2022030921483262400_B18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/10428190903572201","article-title":"Human immunodeficiency virus-associated anaplastic large cell lymphoma","volume":"51","author":"Perez","year":"2010","journal-title":"Leuk Lymphoma."},{"issue":"11","key":"2022030921483262400_B19","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","article-title":"Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study","volume":"4","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2017","journal-title":"Lancet HIV."},{"issue":"4","key":"2022030921483262400_B20","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/S2352-3018(18)30360-6","article-title":"Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study","volume":"6","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2019","journal-title":"Lancet HIV."},{"issue":"14","key":"2022030921483262400_B21","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1182\/bloodadvances.2021004458","article-title":"HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis","volume":"5","author":"Alderuccio","year":"2021","journal-title":"Blood Adv."},{"issue":"3","key":"2022030921483262400_B22","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood.2020006926","article-title":"Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers","volume":"137","author":"Evens","year":"2021","journal-title":"Blood."},{"issue":"5","key":"2022030921483262400_B23","first-page":"704","article-title":"The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy","volume":"90","author":"Navarro","year":"2005","journal-title":"Haematologica."},{"issue":"33","key":"2022030921483262400_B24","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1200\/JCO.2011.41.4193","article-title":"HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era","volume":"30","author":"Montoto","year":"2012","journal-title":"J Clin Oncol."},{"issue":"17","key":"2022030921483262400_B25","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/cncr.30112","article-title":"Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: analysis of the National Cancer Data Base","volume":"122","author":"Olszewski","year":"2016","journal-title":"Cancer."},{"issue":"2","key":"2022030921483262400_B26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/ije\/dyl286","article-title":"Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)","volume":"36","author":"Gange","year":"2007","journal-title":"Int J Epidemiol."},{"issue":"7","key":"2022030921483262400_B27","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/cncr.30416","article-title":"A prospective cohort study of patients with peripheral T-cell lymphoma in the United States","volume":"123","author":"Carson","year":"2017","journal-title":"Cancer."},{"issue":"9","key":"2022030921483262400_B28","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/cncr.31861","article-title":"The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: report from COMPLETE, a prospective, multicenter cohort study","volume":"125","author":"Park","year":"2019","journal-title":"Cancer."},{"issue":"6","key":"2022030921483262400_B29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ajh.25463","article-title":"Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry","volume":"94","author":"Stuver","year":"2019","journal-title":"Am J Hematol."},{"issue":"7","key":"2022030921483262400_B30","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/M14-2768","article-title":"persons with HIV in North America: a cohort study","volume":"163","author":"Silverberg","year":"2015","journal-title":"Ann Intern Med."},{"issue":"12","key":"2022030921483262400_B31","doi-asserted-by":"crossref","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS One."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/5\/1420\/1879664\/advancesadv2021006208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/5\/1420\/1879664\/advancesadv2021006208.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T21:48:55Z","timestamp":1646862535000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/5\/1420\/483519\/Comparative-outcomes-for-mature-T-cell-and-NK-T"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,3,8]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021006208","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]}}}